Evaluation of the efficacy of a topical chamomile-pumpkin oleogel for the treatment of plaque psoriasis: an intra-patient, double-blind, randomized clinical trial
Open Access
- 5 November 2018
- journal article
- research article
- Published by Biomedical Research and Therapy in Biomedical Research and Therapy
- Vol. 5 (11), 2811-2819
- https://doi.org/10.15419/bmrat.v5i11.499
Abstract
Background: Plaque psoriasis is a chronic inflammatory skin disease. Conventional treatments of psoriasis are not completely effective. In addition, unwanted side effects limit their long-term use. In this regard, developing new natural treatments with fewer side effects could be an alternative option. This study was designed to evaluate the efficacy and safety of topical chamomile-pumpkin oleogel (ChP) in treating plaque psoriasis. Methods: A total of 40 patients with mild-to-moderate plaque psoriasis were enrolled in this intra-patient, double-blind, block-randomized clinical trial. In each patient, bilateral symmetrical plaques were treated with ChP or placebo twice daily for four weeks. For clinical assessment, the Psoriasis Severity Index (PSI) and the Physician's Global Assessment (PGA) scale were evaluated at baseline and after the treatment. At the end of the study, patients' satisfaction with the treatment was evaluated using a visual analog scale (VAS) ranging from 0 to 10. For safety assessment, all treatment-related side effects were recorded. Results: Thirty-seven subjects (20 female, 17 male; age 20–60 years) completed the study. The mean decreases in the PSI score in the ChP group (4.09 +/- 2.24) were significantly (p = 0.000) greater than the placebo group (0.48 +/- 1.39). According to the PGA results, 13/37 (35%) of the ChP-treated plaques could achieve marked to complete improvement compared to 0% in the placebo group. Three patients dropped out from the study due to worsening of bilateral plaques during the first week of trial. Conclusion: Our results suggest that topically applied ChP could provide a safe and effective complementary option for psoriasis plaque management. IRCT registration code: IRCT2016092830030N1.Keywords
This publication has 28 references indexed in Scilit:
- New insights of T cells in the pathogenesis of psoriasisCellular & Molecular Immunology, 2012
- Amended Safety Assessment of Sesamum Indicum (Sesame) Seed Oil, Hydrogenated Sesame Seed Oil, Sesamum Indicum (Sesame) Oil Unsaponifiables, and Sodium SesameseedateInternational Journal of Toxicology, 2011
- Chamomile: A herbal medicine of the past with a bright future (Review)Molecular Medicine Reports, 2010
- Healing fats of the skin: the structural and immunologic roles of the ω-6 and ω-3 fatty acidsClinics in Dermatology, 2010
- Complementary and alternative medicine for psoriasis: A qualitative review of the clinical trial literatureJournal of the American Academy of Dermatology, 2009
- Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activityLife Sciences, 2009
- Oxidative stress in the pathogenesis of psoriasisFree Radical Biology & Medicine, 2009
- Psoriasis: Improving adherence to topical therapyJournal of the American Academy of Dermatology, 2008
- Topical treatments in psoriasis: today and tomorrowClinics in Dermatology, 2008
- Psoriasis pathophysiology: current concepts of pathogenesisAnnals Of The Rheumatic Diseases, 2005